Ticker > Company >

Prevest Denpro share price

Prevest Denpro Ltd.

BSE: 543363 SECTOR: Medical Equipment/Supplies/Accessories  47.13 K   327   10

565.00
0 0
BSE: 29 Aug 04:01 PM

Price Summary

Today's High

₹ 568.5

Today's Low

₹ 551.15

52 Week High

₹ 686

52 Week Low

₹ 393.6

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

678.17 Cr.

Enterprise Value

617.71 Cr.

No. of Shares

1.2 Cr.

P/E

35.35

P/B

6.15

Face Value

₹ 10

Div. Yield

0.18 %

Book Value (TTM)

₹  91.84

CASH

60.46 Cr.

DEBT

0 Cr.

Promoter Holding

73.6 %

EPS (TTM)

₹  15.98

Sales Growth

11.74%

ROE

18.74 %

ROCE

25.26%

Profit Growth

12.89 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year11.74%
3 Year18.28%
5 Year22.6%

Profit Growth

1 Year12.89%
3 Year16.31%
5 Year29.44%

ROE%

1 Year18.74%
3 Year20.97%
5 Year26.02%

ROCE %

1 Year25.26%
3 Year28.1%
5 Year34.18%

Debt/Equity

0

Price to Cash Flow

45.28

Interest Cover Ratio

96.5618

CFO/PAT (5 Yr. Avg.)

0.764629286766864

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 73.60 0.00
Mar 2025 73.60 0.00
Dec 2024 73.60 0.00
Sep 2024 73.60 0.00
Jun 2024 73.60 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 16.3066905505681% for the Past 3 years.
  • The company has shown a good revenue growth of 18.281551943924% for the Past 3 years.
  • Company has been maintaining healthy ROE of 20.9714666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 28.1030666666667% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 96.5618.
  • The Company has been maintaining an effective average operating margins of 35.4787844092114% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 46.1833 days.
  • Company has a healthy liquidity position with current ratio of 14.0586.
  • The company has a high promoter holding of 73.6%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 13.34 16.26 14.93 18.54 15.72
Total Expenditure 8.86 10.44 9.79 11.92 10.19
Operating Profit 4.49 5.81 5.14 6.62 5.53
Other Income 0.86 1.07 1.1 1.08 1.17
Interest 0 0 0 0 0
Depreciation 0.48 0.47 0.48 0.47 0.49
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.88 6.41 5.76 7.23 6.21
Tax 1.22 1.57 1.29 1.99 1.58
Profit After Tax 3.65 4.84 4.46 5.25 4.63
Adjusted EPS (Rs) 3.04 4.03 3.72 4.37 3.86

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 28.48 38.11 49.85 56.44 63.07
Total Expenditure 19.45 22.89 30.05 36.4 40.75
Operating Profit 9.02 15.22 19.81 20.04 22.32
Other Income 1.04 1.62 2.03 2.86 4.11
Interest 0.25 0.27 0.21 0.21 0.25
Depreciation 0.47 0.52 0.68 1.28 1.9
Exceptional Items 0 0 0 0 0
Profit Before Tax 9.34 16.05 20.96 21.41 24.27
Tax 2.13 4.48 5.25 5.29 6.07
Net Profit 7.21 11.57 15.71 16.12 18.2
Adjusted EPS (Rs.) 8.16 9.64 13.09 13.43 15.16

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.29 12 12 12 12
Total Reserves 22.21 45.08 60.79 76.6 93.6
Borrowings 1.39 1.37 0 0 0
Other N/C liabilities 0.24 0.29 0.37 0.69 1
Current liabilities 6.55 5.4 5.44 5.52 6.07
Total Liabilities 30.68 64.14 78.61 94.81 112.67
Assets
Net Block 5.36 6.72 7.41 26.75 26.8
Capital WIP 1.71 4.72 16.89 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0.05 0.48
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 23.6 52.7 54.32 68.02 85.4
Total Assets 30.68 64.14 78.61 94.81 112.67
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 9.34 16.05 20.96 21.41 24.27
Adjustment 0.15 -0.6 -0.94 -1.22 -1.78
Changes in Assets & Liabilities 1.17 -4.06 -4.42 -4.08 -1.49
Tax Paid -1.9 -4.43 -5.16 -4.62 -6.03
Operating Cash Flow 8.76 6.96 10.43 11.49 14.98
Investing Cash Flow -1.93 -3.87 -12.38 -1.75 -1.74
Financing Cash Flow -0.57 22.82 -1.37 -0.32 -1.2
Net Cash Flow 6.26 25.91 -3.32 9.42 12.04

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 73.60 73.60 73.60 73.60 73.60
alka beotra 0.03 0.03 0.03 0.03 0.03
atul modi 37.52 37.52 37.52 37.52 37.52
namrata modi 36.03 36.03 36.03 36.03 36.03
niharika modi 0.03 0.03 0.03 0.03 0.03
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 26.40 26.40 26.40 26.40 26.40
pushpa kumari pankaj pras... - - - 2.47 2.58
sharad kanayalal shah 1.08 1.08 1.08 1.08 1.08
thermo capital private li... - - - 1.07 1.10
pankaj prasoon - 2.07 2.47 - -
thermo pads private limit... 1.15 - 1.06 - -

Annual Reports

Title Link
Title Link
Annual Report 2020
Annual Report 2019

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research Nuvama

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY22
Concall Q3FY24
Concall Q3FY23
Concall Q3FY22
Concall Q3FY22
Concall Q2FY23
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q3FY24
Presentation Q3FY22

Company News

Prevest Denpro - Quaterly Results 13 Aug, 7:40 PM Prevest Denpro - Quaterly Results 13 Aug, 7:40 PM Prevest Denpro wins ‘Vyapar Ratna’ Award 9 Jul, 4:21 PM Prevest Denpro signs MoU with Indian Dental Association 9 Jun, 12:21 PM Prevest Denpro - Quaterly Results 27 May, 7:18 PM Prevest Denpro - Quaterly Results 27 May, 7:18 PM Prevest Denpro - Quaterly Results 1 Feb, 5:57 PM Prevest Denpro - Quaterly Results 1 Feb, 5:57 PM Prevest Denpro - Quaterly Results 1 Feb, 5:57 PM Prevest Denpro submits board meeting intimation 27 Jan, 5:28 PM Prevest Denpro - Quaterly Results 11 Nov, 5:29 PM Prevest Denpro - Quaterly Results 11 Nov, 5:29 PM Prevest Denpro informs about certificate 19 Oct, 3:30 PM Prevest Denpro - Quaterly Results 8 Aug, 4:54 PM Prevest Denpro - Quaterly Results 8 Aug, 4:54 PM Prevest Denpro - Quaterly Results 8 Aug, 4:54 PM Prevest Denpro informs about audio recording of earning call 1 Jun, 12:33 PM Prevest Denpro - Quaterly Results 28 May, 4:50 PM Prevest Denpro - Quaterly Results 28 May, 4:50 PM Prevest Denpro - Quaterly Results 3 Feb, 5:48 PM Prevest Denpro - Quaterly Results 3 Feb, 5:48 PM Prevest Denpro - Quaterly Results 3 Feb, 5:48 PM Prevest Denpro informs about press release 23 Nov, 12:51 PM Prevest Denpro launches oral care product segment ‘Oradox’ 23 Nov, 10:46 AM Prevest Denpro informs about audio recording of earning call 10 Nov, 12:11 PM Prevest Denpro - Quaterly Results 3 Nov, 5:28 PM Prevest Denpro - Quaterly Results 3 Nov, 5:28 PM Prevest Denpro informs about compliance certificate 16 Oct, 5:24 PM Prevest Denpro informs about voting results of AGM and scrutinizer's report 1 Sep, 10:05 AM Prevest Denpro informs about investor presentation 8 Aug, 10:51 AM Prevest Denpro - Quaterly Results 3 Aug, 3:20 AM Prevest Denpro - Quaterly Results 3 Aug, 3:20 AM Prevest Denpro - Quaterly Results 3 Aug, 3:20 AM Prevest Denpro launches latest oral care product line ‘Oradox’ 31 Jul, 3:30 PM Prevest Denpro signs MoU with Sri Vishnu Educational Society 31 Jul, 2:58 PM Prevest Denpro informs about trading window closure 1 Jul, 11:05 AM Prevest Denpro incorporates wholly owned subsidiary 22 May, 2:57 PM Prevest Denpro informs about disclosure 16 May, 12:00 PM Prevest Denpro informs about press release 8 May, 4:55 PM Prevest Denpro informs about investor presentation 8 May, 11:26 AM Prevest Denpro - Quaterly Results 27 Apr, 2:25 PM Prevest Denpro - Quaterly Results 27 Apr, 2:25 PM Prevest Denpro - Quaterly Results 27 Apr, 2:25 PM Prevest Denpro - Quaterly Results 13 Feb, 1:04 PM Prevest Denpro - Quaterly Results 13 Feb, 1:04 PM Prevest Denpro - Quaterly Results 13 Feb, 1:04 PM Prevest Denpro informs about trading window closure 29 Dec, 3:12 PM Prevest Denpro informs about disclosures 26 Dec, 12:48 PM Prevest Denpro informs about disclosure 26 Dec, 12:27 PM Prevest Denpro informs about board meeting 3 Nov, 4:10 PM

Prevest Denpro Stock Price Analysis and Quick Research Report. Is Prevest Denpro an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Prevest Denpro. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Prevest Denpro has a PE ratio of 35.3544834490958 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Prevest Denpro has ROA of 17.5443% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Prevest Denpro has a Current ratio of 14.0586.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Prevest Denpro has a ROE of 18.744%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Prevest Denpro has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Prevest Denpro has reported revenue growth of 11.7433% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Prevest Denpro for the current financial year is 35.3886379240086%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Prevest Denpro is Rs 1 and the yield is 0.177%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Prevest Denpro is Rs 15.981. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Prevest Denpro in Ticker for free. Also, one can get the intrinsic value of Prevest Denpro by using Valuation Calculators, which are available with a Finology ONE subscription. 

Prevest Denpro FAQs

Q1. What is Prevest Denpro share price today?
Ans: The current share price of Prevest Denpro is Rs 565.

Q2. What is the market capitalisation of Prevest Denpro?
Ans: Prevest Denpro has a market capitalisation of Rs 678.1695 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Prevest Denpro?
Ans: The PE ratio of Prevest Denpro is 35.3544834490958 and the P/B ratio of Prevest Denpro is 6.15185611842922, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Prevest Denpro share?
Ans: The 52-week high share price of Prevest Denpro is Rs 686, and the 52-week low share price of Prevest Denpro is Rs 393.6.

Q5. Does Prevest Denpro pay dividends?
Ans: Currently, Prevest Denpro pays dividends. Dividend yield of Prevest Denpro is around 0.177%.

Q6. What are the face value and book value of Prevest Denpro shares?
Ans: The face value of Prevest Denpro shares is Rs 10, while the book value per share of Prevest Denpro is around Rs 91.8422. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Prevest Denpro?
Ans: Prevest Denpro has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Prevest Denpro?
Ans: The ROE of Prevest Denpro is 18.744% and ROCE of Prevest Denpro is 25.258%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Prevest Denpro a good buy for the long term?
Ans: The Prevest Denpro long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Prevest Denpro undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Prevest Denpro appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Prevest Denpro’s financials?
Ans: You can review Prevest Denpro’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Prevest Denpro
X